Watch the webcast, in which oncology market research experts Sue Marett, Phil Rosenberg and Claire Fradet Aubignat will explore the key features of the immuno-oncology market and outline the critical success factors that manufacturers need to consider in order to remain competitive.
What are the key takeaways?
Setting the context: The current situation in immuno-oncology and challenges and opportunities for new targeted therapies entering the market.
Portfolio Panning: Understanding where to invest in the early stages of new product development in order to achieve your objectives.
Marketing and communications: Considerations for the positioning and marketing communications strategy with regards to the evolution of each indication. How this will impact your market research needs.
Biomarker strategies: The impact of biomarker availability on patient selection and sequencing. How to ensure your biomarker strategies are optimised for your brand.